The Phenomix CEO discusses recent data that suggests that patients may not be prepared for the side effects and unexpected costs of GLP-1s. GLP-1 drugs continue to dominate the pharmaceutical ...

Coming through the pandemic, healthcare organizations are ramping up their use of digital technology as they redefine healthcare delivery. The rapid adoption of telehealth in crisis demonstrates their ...